Biocon has informed that it enclosed the press release titled ‘Biocon’s S&P Global ESG Score Improves to 69 for 2024; Biocon Biologics Debuts with S&P Global ESG Score of 53’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.